Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.1 | - |
NAV | ₹11.96 | - |
Fund Started | 16 Oct 2023 | - |
Fund Size | ₹91.22 Cr | - |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 18.49% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 83.68% | - |
Cash | 16.32% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Eris Lifesciences Ltd. | 2.89% |
Supriya Lifescience Ltd. | 2.86% |
Karur Vysya Bank Ltd. | 2.77% |
EPL Ltd. | 2.64% |
ICICI Prudential Life Insurance Company Ltd. | 2.53% |
CMS Info Systems Ltd. | 2.50% |
MPS Ltd. | 2.30% |
Mayur Uniquoters Ltd. | 2.30% |
Genus Power Infrastructures Ltd. | 2.28% |
HDFC Bank Ltd. | 2.27% |
Name | Chirag Mehta | - |
Start Date | 01 Apr 2017 | - |
Name
Start Date
Description | The Scheme seeks to generate capital appreciation by investing predominantly in Small Cap Stocks. There is no assurance that the investment objective of the scheme will be achieved. | - |
Launch Date | 16 Oct 2023 | - |
Description
Launch Date